AlphaCrest Capital Management’s Patterson-UTI PTEN Stock Holding History

AlphaCrest Capital Management’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,842	Closed	-$185K	–	879
2022 Q3	$185K	Buy	+15,842	New	+$226K	0.01%	1240
2022 Q2	–	Sell	-12,062	Closed	-$187K	–	1347
2022 Q1	$187K	Buy	+12,062	New	+$152K	0.01%	1214
2020 Q1	–	Sell	-29,771	Closed	-$313K	–	1229
2019 Q4	$313K	Buy	+29,771	New	+$269K	0.03%	1040
2019 Q2	–	Sell	-21,017	Closed	-$295K	–	1115
2019 Q1	$295K	Sell	21,017 -9,083	-30%	-$119K	0.04%	665
2018 Q4	$312K	Buy	+30,100	New	+$444K	0.09%	434

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

ACM

Anomaly Capital Management New York $1.65B AUM 26.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AlphaCrest Capital Management's PTEN Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Patterson-UTI (PTEN) in Q4 2022, closing a stake of 15,842 shares — an estimated $185K sold.

AlphaCrest Capital Management first reported a position in PTEN in Q4 2018 and held it in 5 quarters. The position peaked at $313K in Q4 2019. 307 funds tracked by Wall St. Rank hold PTEN as of Q4 2022.

AlphaCrest Capital Management reported no remaining Patterson-UTI position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 15,842 Patterson-UTI shares in Q4 2022, an estimated $185K.
AlphaCrest Capital Management first reported a position in Patterson-UTI in Q4 2018 and held it in 5 quarters.
AlphaCrest Capital Management's Patterson-UTI position peaked at $313K in Q4 2019.
307 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.